Lv21
140 积分 2023-03-06 加入
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
4小时前
待确认
Safety assessment of antibody-drug conjugates: Nonclinical toxicology, non-active ingredients, and environmental risk considerations
1个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1个月前
已完结
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
3个月前
已完结
Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise
4个月前
已完结
皖公网安备34019202002308
